{"data":{"filter_options":{"titles":[{"name":"Managing Partner Atlanta Office","value":"Managing Partner Atlanta Office"},{"name":"Partner","value":"Partner"},{"name":"Partner / Head of Pro Bono","value":"Partner / Head of Pro Bono"},{"name":"Partner / Chief Operating Officer","value":"Partner / Chief Operating Officer"},{"name":"Partner / General Counsel","value":"Partner / General Counsel"},{"name":"Partner / Dir. E-Discovery Ops","value":"Partner / Dir. E-Discovery Ops"},{"name":"Partner / Chairman, Saudi Arabia Practice","value":"Partner / Chairman, Saudi Arabia Practice"},{"name":"K\u0026S Talent Partner","value":"K\u0026S Talent Partner"},{"name":"Partner / Chief Human Resources Officer","value":"Partner / Chief Human Resources Officer"},{"name":"Chairman","value":"Chairman"},{"name":"Senior Counsel","value":"Senior Counsel"},{"name":"Associate Director, E-Discovery Operations","value":"Associate Director, E-Discovery Operations"},{"name":"Counsel","value":"Counsel"},{"name":"Senior Associate","value":"Senior Associate"},{"name":"Associate","value":"Associate"},{"name":"Senior Attorney","value":"Senior Attorney"},{"name":"Senior Lawyer","value":"Senior Lawyer"},{"name":"Attorney","value":"Attorney"},{"name":"Senior Counsel and Policy Advisor","value":"Senior Counsel and Policy Advisor"},{"name":"Managing Director - Capital Solutions","value":"Managing Director - Capital Solutions"},{"name":"Senior Government Relations Advisor","value":"Senior Government Relations Advisor"},{"name":"Associate General Counsel","value":"Associate General Counsel"},{"name":"Senior Advisor","value":"Senior Advisor"},{"name":"Patent Agent","value":"Patent Agent"},{"name":"Consultant","value":"Consultant"},{"name":"Government Relations Advisor","value":"Government Relations Advisor"},{"name":"Chief of Lateral Partner Recruiting \u0026 Integration","value":"Chief of Lateral Partner Recruiting \u0026 Integration"},{"name":"Chief Financial Officer","value":"Chief Financial Officer"},{"name":"Chief Information Officer","value":"Chief Information Officer"},{"name":"Chief Revenue Officer","value":"Chief Revenue Officer"},{"name":"Chief Recruiting Officer","value":"Chief Recruiting Officer"},{"name":"Chief Lawyer Talent Development Officer","value":"Chief Lawyer Talent Development Officer"},{"name":"Chief Marketing Officer","value":"Chief Marketing Officer"},{"name":"Tax Consultant","value":"Tax Consultant"},{"name":"Director of Community Affairs","value":"Director of Community Affairs"},{"name":"Director of Facilities \u0026 Admin Operations","value":"Director of Facilities \u0026 Admin Operations"},{"name":"Senior Office Manager","value":"Senior Office Manager"},{"name":"Director of Operations","value":"Director of Operations"},{"name":"Pro Bono Deputy","value":"Pro Bono Deputy"},{"name":"Director of Office Operations","value":"Director of Office Operations"},{"name":"Director of Operations Europe","value":"Director of Operations Europe"},{"name":"Law Clerk","value":"Law Clerk"},{"name":"Deputy General Counsel","value":"Deputy General Counsel"}],"schools":[{"name":"(Commercial Law), in front of Monash University, Australia","value":3045},{"name":"Aberystwyth University","value":3004},{"name":"Albany Law School","value":2118},{"name":"American University Washington College of Law","value":3042},{"name":"American University, Washington College of Law","value":3024},{"name":"Appalachian School of Law","value":2891},{"name":"Ateneo de Manila University","value":2914},{"name":"Ave Maria School of Law","value":2892},{"name":"Baylor University School of Law","value":181},{"name":"Benjamin N. Cardozo School of Law","value":2619},{"name":"Binghamton University","value":3002},{"name":"Boston College Law School","value":245},{"name":"Boston University School of Law","value":247},{"name":"BPP Law School Leeds","value":2642},{"name":"BPP Law School London","value":2782},{"name":"BPP University","value":2984},{"name":"Brooklyn Law School","value":2705},{"name":"Cairo University, Law School","value":2962},{"name":"California Western School of Law","value":315},{"name":"Capital University Law School","value":327},{"name":"Case Western Reserve University School of Law","value":345},{"name":"Cecil C. Humphreys School of Law","value":2235},{"name":"Chapman University School of Law","value":377},{"name":"Charleston School of Law","value":2910},{"name":"City Law School, London","value":2998},{"name":"City Law School","value":2857},{"name":"Clark University","value":3006},{"name":"Cleveland-Marshall College of Law","value":426},{"name":"Columbia University School of International and Public Affairs","value":3008},{"name":"Columbia University School of Law","value":485},{"name":"Columbia University","value":3126},{"name":"Columbus School of Law, Catholic University of America","value":3010},{"name":"Columbus School of Law","value":350},{"name":"Concord Law School of Kaplan University","value":1026},{"name":"Cornell Law School","value":512},{"name":"Creighton University School of Law","value":518},{"name":"Creighton University","value":3025},{"name":"Cumberland School of Law","value":1759},{"name":"CUNY School of Law","value":2893},{"name":"David A. Clarke School of Law","value":2399},{"name":"Deakin University School of Law","value":2907},{"name":"DePaul University College of Law","value":565},{"name":"DePaul University College of Law","value":3060},{"name":"Dickinson School of Law","value":2719},{"name":"Drake University Law School","value":609},{"name":"Duke University School of Law","value":613},{"name":"Duquesne University School of Law","value":614},{"name":"Dwayne O. Andreas School of Law","value":173},{"name":"Edinburgh Law School","value":3160},{"name":"Emory University School of Law","value":659},{"name":"ESADE Business and Law School – Universidad Ramon Llull","value":3215},{"name":"Fachseminare von Fürstenberg","value":2918},{"name":"Faculté Libre de Droit, Université Catholique de Lille","value":3055},{"name":"Faculty of Law, University of Zagreb","value":2983},{"name":"Faculty of Law","value":2944},{"name":"Faculty of Law","value":3039},{"name":"Federal University of Rio de Janeiro","value":3022},{"name":"Federal University of Rio Grande do Sul School of Law (Brazil)","value":3062},{"name":"Florida A\u0026M University College of Law","value":699},{"name":"Florida Coastal School of Law","value":2894},{"name":"Florida International College of Law","value":707},{"name":"Florida State University College of Law","value":720},{"name":"Fordham University School of Law","value":722},{"name":"Franklin Pierce Law Center","value":734},{"name":"Friedrich-Schiller-Universität Jena","value":3015},{"name":"George Mason University School of Law","value":752},{"name":"George Washington University Law School","value":753},{"name":"Georgetown University Law Center","value":755},{"name":"Georgia State University College of Law","value":761},{"name":"Ghent Law School","value":2793},{"name":"Golden Gate University School of Law","value":770},{"name":"Gonzaga University School of Law","value":772},{"name":"Graduate Institute of International and Development Studies, Geneva","value":2997},{"name":"Hamline University School of Law","value":811},{"name":"Harvard Law School","value":824},{"name":"Hebrew University of Jerusalem Faculty of Law","value":2994},{"name":"Hofstra University School of Law","value":858},{"name":"Howard University School of Law","value":872},{"name":"Huazhong University of Science and Technology","value":3016},{"name":"Humboldt University of Berlin","value":3012},{"name":"Indiana University School of Law","value":2711},{"name":"Indiana University School of Law","value":890},{"name":"International Association of Privacy Professionals","value":3009},{"name":"J. Reuben Clark Law School","value":262},{"name":"Jacob D. Fuchsberg Law Center","value":2084},{"name":"James Cook University of North Queensland","value":3034},{"name":"Jean Moulin University Lyon 3, France","value":2938},{"name":"Johns Hopkins Bloomberg School of Public Health","value":2992},{"name":"Justus-Liebig-Universität Gießen Rechtswissenschaft (Germany)","value":3063},{"name":"Kansas City School of Law","value":2247},{"name":"Keio University","value":2968},{"name":"Kent College of Law","value":883},{"name":"Kline School of Law","value":611},{"name":"KU Leuven","value":3007},{"name":"Levin College of Law","value":2189},{"name":"Lewis and Clark Law School","value":1089},{"name":"Liberty University School of Law","value":1094},{"name":"Lincoln College of Law","value":2253},{"name":"LL.M. in International Crime and Justice UNICRI","value":2937},{"name":"Loyola Law School","value":2895},{"name":"Loyola University Chicago School of Law","value":1135},{"name":"Loyola University New Orleans College of Law","value":1136},{"name":"Marquette University Law School","value":1176},{"name":"McGeorge School of Law","value":2402},{"name":"McGill University","value":2659},{"name":"Melbourne Law School","value":2899},{"name":"Mercer University Walter F. George School of Law","value":1221},{"name":"Mexico Autonomous Institute of Technology","value":2996},{"name":"Michael E. Moritz College of Law","value":2728},{"name":"Michigan State University College of Law","value":1245},{"name":"Mississippi College School of Law","value":1285},{"name":"Moscow State University","value":2815},{"name":"National and Kapodistrian University of Athens","value":3032},{"name":"National Law University Jodhpur","value":3020},{"name":"National University of Singapore, Faculty of Law","value":2662},{"name":"New England School of Law","value":2886},{"name":"New York Law School","value":1403},{"name":"New York University School of Law","value":1406},{"name":"Norman Adrian Wiggins School of Law","value":323},{"name":"North Carolina Central University School of Law","value":1417},{"name":"Northeastern University School of Law","value":1430},{"name":"Northern Illinois University College of Law","value":1432},{"name":"Northwestern Pritzker School of Law","value":1451},{"name":"Notre Dame Law School","value":2278},{"name":"Ohio Northern University Law School","value":3036},{"name":"Oklahoma City University School of Law","value":1487},{"name":"Osgoode Hall Law School","value":3124},{"name":"Pace University School of Law","value":1516},{"name":"Panteion University","value":3033},{"name":"Paul M. Hebert Law Center","value":2713},{"name":"Pennsylvania State University, Dickinson School of Law","value":1562},{"name":"Pepperdine University School of Law","value":1570},{"name":"Pettit College of Law","value":1473},{"name":"Pontificia Universidad Catolica de Chile","value":3203},{"name":"Pontificia Universidad Catolica del Peru","value":3011},{"name":"Pontificia Universidad Javeriana","value":3013},{"name":"Pontificia Universidade Catolica de Sao Paulo","value":3095},{"name":"Prince Sultan University College of Law","value":3167},{"name":"Queens College, Cambridge","value":3003},{"name":"Quinnipiac University School of Law","value":1626},{"name":"Ralph R. Papitto School of Law","value":1686},{"name":"Regent University School of Law","value":1649},{"name":"Rice University","value":3043},{"name":"Ruprecht-Karls-Universität Heidelberg","value":3049},{"name":"Rutgers University School of Law-Newark","value":1699},{"name":"Rutgers University School of Law","value":1697},{"name":"S.J. Quinney College of Law","value":2408},{"name":"Saint Louis University School of Law","value":1732},{"name":"Salmon P. Chase College of Law","value":1433},{"name":"Sandra Day O'Connor College of Law","value":103},{"name":"Santa Clara University School of Law","value":1771},{"name":"Seattle University School of Law","value":1787},{"name":"Seton Hall University School of Law","value":1790},{"name":"Shepard Broad Law Center","value":1460},{"name":"South Texas College of Law","value":2721},{"name":"Southern Illinois University School of Law","value":1849},{"name":"Southern Methodist University Dedman School of Law","value":1852},{"name":"Southern University Law Center","value":1857},{"name":"Southwestern Law School","value":1876},{"name":"St. John's University School of Law","value":2724},{"name":"St. Mary's University School of Law","value":1896},{"name":"St. Thomas University School of Law","value":1746},{"name":"Stanford Law School","value":1904},{"name":"Stetson University College of Law","value":1910},{"name":"Sturm College of Law","value":2184},{"name":"Suffolk University Law School","value":1921},{"name":"Syracuse University College of Law","value":1956},{"name":"Temple University Beasley School of Law","value":1974},{"name":"Texas A\u0026M School of Law","value":1980},{"name":"Texas Tech University School of Law","value":1994},{"name":"Texas Wesleyan University School of Law","value":1996},{"name":"The College of Law Australia","value":3091},{"name":"The College of Law, London","value":2935},{"name":"The John Marshall Law School","value":2034},{"name":"The Judge Advocate General's Legal Center and School","value":2896},{"name":"The Ohio State University Moritz College of Law","value":2990},{"name":"The University of Akron School of Law","value":2143},{"name":"The University of Alabama School of Law","value":2045},{"name":"The University of Birmingham, U.K.","value":2796},{"name":"The University of Iowa College of Law","value":2206},{"name":"The University of Texas School of Law","value":2055},{"name":"The University of Tulsa College of Law","value":2407},{"name":"Thomas Jefferson School of Law","value":685},{"name":"Thomas M. Cooley Law School","value":2729},{"name":"Thurgood Marshall School of Law","value":1992},{"name":"Tianjin University of Commerce","value":2995},{"name":"Tulane University Law School","value":2113},{"name":"UC Davis School of Law","value":2160},{"name":"UCLA School of Law","value":2162},{"name":"Universidad Católica de Honduras","value":2916},{"name":"Universidad Francisco Marroquin","value":3090},{"name":"Universidad Panamericana","value":2904},{"name":"Universidad Torcuato di Tella","value":3035},{"name":"Universidade de São Paulo, Faculdade de Direito","value":3028},{"name":"Universidade Presbiteriana Mackenzie","value":2977},{"name":"Università Commerciale Luigi Bocconi","value":3135},{"name":"University at Buffalo Law School","value":1928},{"name":"University College Dublin Law School","value":2900},{"name":"University of Alberta Faculty of Law","value":3088},{"name":"University of Amsterdam","value":2980},{"name":"University of Arizona, James E. Rogers College of Law","value":2149},{"name":"University of Arkansas School of Law","value":2154},{"name":"University of Baltimore School of Law","value":2156},{"name":"University of California College of the Law","value":3196},{"name":"University of California Hastings College of Law","value":2158},{"name":"University of California Irvine School of Law","value":2161},{"name":"University of California, Berkeley, School of Law","value":2159},{"name":"University of California, Davis","value":3019},{"name":"University of Cambridge, U.K","value":2991},{"name":"University of Canterbury","value":2981},{"name":"University of Central Florida","value":3027},{"name":"University of Chester Law School","value":3005},{"name":"University of Chicago Law School","value":2174},{"name":"University of Chicago","value":3038},{"name":"University of Cincinnati College of Law","value":2175},{"name":"University of Colorado School of Law","value":2177},{"name":"University of Connecticut School of Law","value":2180},{"name":"University of Dayton School of Law","value":2182},{"name":"University of Detroit Mercy School of Law","value":2185},{"name":"University of East Anglia","value":3000},{"name":"University of Florida, Levin College of Law","value":3188},{"name":"University of Georgia School of Law","value":2190},{"name":"University of Houston Law Center","value":2197},{"name":"University of Hull","value":3040},{"name":"University of Idaho College of Law","value":2201},{"name":"University of Illinois College of Law","value":2204},{"name":"University of Kansas School of Law","value":2208},{"name":"University of Kentucky College of Law","value":2210},{"name":"University of La Verne College of Law","value":2211},{"name":"University of Law, London","value":2999},{"name":"University of Lethbridge","value":3030},{"name":"University of Louisville Brandeis School of Law","value":2214},{"name":"University of Maine School of Law","value":2391},{"name":"University of Maryland School of Law","value":2224},{"name":"University of Miami School of Law","value":2236},{"name":"University of Michigan Law School","value":2237},{"name":"University of Minnesota Law School","value":2243},{"name":"University of Mississippi School of Law","value":2244},{"name":"University of Missouri School of Law","value":2246},{"name":"University of Montana School of Law","value":2048},{"name":"University of Nebraska College of Law","value":2744},{"name":"University of New Mexico School of Law","value":2262},{"name":"University of North Carolina School of Law","value":2266},{"name":"University of North Dakota School of Law","value":2271},{"name":"University of Oklahoma Law Center","value":2747},{"name":"University of Oregon School of Law","value":2281},{"name":"University of Pennsylvania Law School","value":2282},{"name":"University of Pittsburgh School of Law","value":2354},{"name":"University of Richmond School of Law","value":2370},{"name":"University of San Diego School of Law","value":2377},{"name":"University of San Francisco School of Law","value":2378},{"name":"University of South Carolina School of Law","value":2750},{"name":"University of South Dakota School of Law","value":2387},{"name":"University of Southern California Gould School of Law","value":3051},{"name":"University of St. Thomas School of Law","value":2751},{"name":"University of Sydney Law School","value":3031},{"name":"University of Tennessee College of Law","value":2051},{"name":"University of the West of England, Bristol","value":3001},{"name":"University of Toledo College of Law","value":2406},{"name":"University of Toronto","value":2912},{"name":"University of Utah","value":3026},{"name":"University of Virginia School of Law","value":2410},{"name":"University of Washington School of Law","value":2412},{"name":"University of Wisconsin Law School","value":2419},{"name":"University of Wyoming College of Law","value":2429},{"name":"University of Zürich","value":3037},{"name":"University Paris Dauphine","value":2976},{"name":"University Paris II Assas","value":2975},{"name":"University Paris II Assas","value":3052},{"name":"USC Gould School of Law","value":2389},{"name":"Utrecht University","value":3085},{"name":"Valparaiso University School of Law","value":2441},{"name":"Vanderbilt University School of Law","value":2442},{"name":"Vermont Law School","value":2451},{"name":"Villanova University School of Law","value":2454},{"name":"Wake Forest University School of Law","value":2471},{"name":"Washburn University School of Law","value":2482},{"name":"Washington and Lee University School of Law","value":2484},{"name":"Washington College of Law","value":61},{"name":"Washington University in St. Louis School of Law","value":2489},{"name":"Wayne State University Law School","value":2493},{"name":"West Virginia University College of Law","value":2517},{"name":"Western New England College School of Law","value":2528},{"name":"Western State College of Law","value":2897},{"name":"Wharton School of Business","value":3044},{"name":"Whittier Law School","value":2564},{"name":"Widener University Delaware Law School","value":2569},{"name":"Willamette University College of Law","value":2573},{"name":"William \u0026 Mary Law School","value":462},{"name":"William H. Bowen School of Law","value":2150},{"name":"William Mitchell College of Law","value":2758},{"name":"William S. Boyd School of Law","value":2256},{"name":"William S. Richardson School of Law","value":2195},{"name":"Wilmington University","value":2993},{"name":"Yale Law School","value":2605}],"offices":[{"name":"Abu Dhabi","value":13},{"name":"Atlanta","value":1},{"name":"Austin","value":12},{"name":"Brussels","value":23},{"name":"Charlotte","value":8},{"name":"Chicago","value":21},{"name":"Dallas","value":28},{"name":"Denver","value":22},{"name":"Dubai","value":6},{"name":"Frankfurt","value":9},{"name":"Geneva","value":15},{"name":"Houston","value":4},{"name":"London","value":5},{"name":"Los Angeles","value":19},{"name":"Miami","value":25},{"name":"New York","value":3},{"name":"Northern Virginia","value":24},{"name":"Paris","value":14},{"name":"Riyadh","value":27},{"name":"Sacramento","value":20},{"name":"San Francisco","value":10},{"name":"Silicon Valley","value":11},{"name":"Singapore","value":16},{"name":"Sydney","value":26},{"name":"Tokyo","value":18},{"name":"Washington, D.C.","value":2}],"capabilities":[{"name":"Corporate, Finance and Investments","value":"cg-1"},{"name":"Activist Defense","value":72},{"name":"Capital Markets","value":26},{"name":"Construction and Procurement","value":40},{"name":"Corporate Governance","value":27},{"name":"Emerging Companies and Venture Capital","value":80},{"name":"Employee Benefits and Executive Compensation","value":28},{"name":"Energy and Infrastructure Projects","value":35},{"name":"Financial Restructuring","value":10},{"name":"Fund Finance","value":134},{"name":"Global Human Capital and Compliance ","value":121},{"name":"Investment Funds and Asset Management","value":78},{"name":"Leveraged Finance","value":29},{"name":"Mergers and Acquisitions (M\u0026A)","value":32},{"name":"Middle East and Islamic Finance and Investment","value":31},{"name":"Private Equity","value":33},{"name":"Public Companies","value":126},{"name":"Real Estate","value":36},{"name":"Structured Finance and Securitization","value":82},{"name":"Tax","value":37},{"name":"Technology Transactions","value":115},{"name":"Government Matters","value":"cg-2"},{"name":"Antitrust","value":1},{"name":"Data, Privacy and Security","value":6},{"name":"Environmental, Health and Safety","value":71},{"name":"FDA and Life Sciences","value":21},{"name":"Government Advocacy and Public Policy","value":23},{"name":"Government Contracts","value":116},{"name":"Healthcare","value":24},{"name":"Innovation Protection","value":135},{"name":"International Trade","value":25},{"name":"National Security and Corporate Espionage","value":110},{"name":"Securities Enforcement and Regulation","value":20},{"name":"Special Matters and Government Investigations","value":11},{"name":"Trial and Global Disputes","value":"cg-3"},{"name":"Antitrust ","value":129},{"name":"Appellate, Constitutional and Administrative Law","value":2},{"name":"Bankruptcy and Insolvency Litigation","value":38},{"name":"Class Action Defense","value":3},{"name":"Commercial Litigation","value":5},{"name":"Corporate and Securities Litigation","value":19},{"name":"E-Discovery","value":7},{"name":"Global Construction and Infrastructure Disputes","value":4},{"name":"Innovation Protection","value":136},{"name":"Intellectual Property","value":13},{"name":"International Arbitration and Litigation","value":14},{"name":"Labor and Employment","value":15},{"name":"Product Liability","value":17},{"name":"Professional Liability","value":18},{"name":"Toxic \u0026 Environmental Torts","value":16},{"name":"Industries / Issues","value":"cg-4"},{"name":"Artificial Intelligence (AI) and Machine Learning","value":133},{"name":"Automotive, Transportation and Mobility","value":106},{"name":"Buy American","value":124},{"name":"Crisis Management","value":111},{"name":"Doing Business in Latin America","value":132},{"name":"Energy Transition","value":131},{"name":"Energy","value":102},{"name":"Environmental Agenda","value":125},{"name":"Environmental, Social and Governance (ESG)","value":127},{"name":"Financial Services","value":107},{"name":"Focus on Women's Health","value":112},{"name":"Food and Beverage","value":105},{"name":"Higher Education","value":109},{"name":"Life Sciences and Healthcare","value":103},{"name":"Russia/Ukraine","value":128},{"name":"Special Purpose Acquisition Companies (SPACs)","value":123},{"name":"Technology","value":118}]},"title_id":null,"school_id":null,"office_id":null,"capability_id":"128","extra_filter_id":null,"extra_filter_type":null,"q":null,"starts_with":"K","per_page":12,"people":[{"id":440298,"version":1,"owner_type":"Person","owner_id":2100,"payload":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","slug":"amanda-klingler","email":"aklingler@kslaw.com","phone":null,"matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":174}]},"expertise":[{"id":81,"guid":"81.capabilities","index":0,"source":"capabilities"},{"id":103,"guid":"103.capabilities","index":1,"source":"capabilities"},{"id":21,"guid":"21.capabilities","index":2,"source":"capabilities"},{"id":17,"guid":"17.capabilities","index":3,"source":"capabilities"},{"id":114,"guid":"114.capabilities","index":4,"source":"capabilities"},{"id":122,"guid":"122.capabilities","index":5,"source":"capabilities"},{"id":1199,"guid":"1199.smart_tags","index":6,"source":"smartTags"},{"id":1202,"guid":"1202.smart_tags","index":7,"source":"smartTags"},{"id":1223,"guid":"1223.smart_tags","index":8,"source":"smartTags"},{"id":128,"guid":"128.capabilities","index":9,"source":"capabilities"},{"id":133,"guid":"133.capabilities","index":10,"source":"capabilities"},{"id":1206,"guid":"1206.smart_tags","index":11,"source":"smartTags"}],"is_active":true,"last_name":"Klingler","nick_name":"Amanda","clerkships":[],"first_name":"Amanda","title_rank":9999,"updated_by":202,"law_schools":[],"middle_name":"J.","name_suffix":"","recognitions":null,"linked_in_url":null,"seodescription":null,"primary_title_id":15,"translated_fields":{"en":{"bio":"\u003cp\u003eAmanda Klingler is a partner in the firm\u0026rsquo;s Washington, D.C. and Chicago offices with extensive experience advising life science clients.\u0026nbsp; As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003eAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.\u0026nbsp; Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.\u0026nbsp; She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.\u0026nbsp;\u0026nbsp;Amanda, as a co-leader of the firm\u0026rsquo;s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003eAmanda advises clients during internal and government investigations.\u0026nbsp; She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\u003c/p\u003e\n\u003cp\u003eAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\u003c/p\u003e\n\u003cp\u003eAmanda also has significant experience and expertise in FDA's regulation of tobacco products.\u003c/p\u003e","matters":["\u003cp\u003e\u003cem\u003ePhillips Morris USA v. FDA,\u0026nbsp;\u003c/em\u003e202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eproduct liability litigation\u003c/strong\u003einvolving GlaxoSmithKline\u0026rsquo;s antidepressant Paxil\u0026reg;, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003ein limine\u003c/em\u003e\u0026nbsp;and\u0026nbsp;\u003cem data-redactor-tag=\"em\"\u003eDaubert\u003c/em\u003echallenges.\u003c/p\u003e","\u003cp\u003eMember of a King \u0026amp; Spalding team representing the\u0026nbsp;\u003cstrong\u003emanufacturer of FDA-cleared surgical gowns\u0026nbsp;\u003c/strong\u003ein nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a\u0026nbsp;\u003cem\u003equi tam\u0026nbsp;\u003c/em\u003esuit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003ecompanies in preparing for FDA inspections,\u003c/strong\u003e\u0026nbsp;developing responses to FDA investigational observations (FDA-483 forms), and warning letters.\u003c/p\u003e","\u003cp\u003eAssisted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003epharmaceutical and medical device companies\u003c/strong\u003e\u0026nbsp;under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong\u003einternal investigations of pharmaceutical medical device manufacturers\u003c/strong\u003e\u0026nbsp;into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.\u003c/p\u003e","\u003cp\u003eConducted\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFDA regulatory due diligence reviews\u003c/strong\u003e\u0026nbsp;of target medical device, pharmaceutical manufacturers, and compounding pharmacies.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eradiation-emitting product requirements\u003c/strong\u003e\u0026nbsp;under the FDCA.\u003c/p\u003e","\u003cp\u003eCounseled companies on\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003elabeling and promotion requirements\u003c/strong\u003e\u0026nbsp;for FDA-regulated products.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eUnited States v. Franck\u0026rsquo;s Lab\u003c/em\u003e, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003eFranck\u0026rsquo;s Lab\u003c/strong\u003e\u0026nbsp;in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA\u0026rsquo;s statute. Also served as the lead associate for Franck\u0026rsquo;s Lab in other FDA regulatory and state board of pharmacy matters.\u003c/p\u003e","\u003cp\u003e\u003cem data-redactor-tag=\"em\"\u003eHill Dermaceuticals, Inc. v.\u003c/em\u003e\u0026nbsp;FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing\u0026nbsp;\u003cstrong data-redactor-tag=\"strong\"\u003einnovator drug manufacturer\u003c/strong\u003e\u0026nbsp;in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer\u0026rsquo;s brand name products.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":4350}]},"capability_group_id":2},"created_at":"2025-10-08T19:11:18.000Z","updated_at":"2025-10-08T19:11:18.000Z","searchable_text":"Klingler{{ FIELD }}Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products.{{ FIELD }}Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges.{{ FIELD }}Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony.{{ FIELD }}Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters.{{ FIELD }}Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA.{{ FIELD }}Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure.{{ FIELD }}Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies.{{ FIELD }}Counseled companies on radiation-emitting product requirements under the FDCA.{{ FIELD }}Counseled companies on labeling and promotion requirements for FDA-regulated products.{{ FIELD }}United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters.{{ FIELD }}Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.{{ FIELD }}Amanda Klingler is a partner in the firm’s Washington, D.C. and Chicago offices with extensive experience advising life science clients.  As a partner in the firm's FDA and Life Sciences practice, Amanda advises pharmaceutical, medical device and biotech companies and pharmacies, on a wide range of regulatory matters, enforcement actions, civil litigation, investigations, product liability litigation, and compliance counseling. \nAmanda counsels clients on pre- and post-marketing regulatory activities and strategies, including obtaining FDA approval and clearance for medical products.  Amanda also regularly advises clients on product labeling, adverse event reporting, product safety issues, recalls/field corrections, import detention, and advertising and promotion issues.  She counsels clients on quality system and manufacturing practices for drugs and medical devices and factory inspections, including conducting mock inspections and working closely with and providing advice to clients during the inspection, and provide guidance in responding to FDA investigational observations (FDA-483 forms), and warning letters.  Amanda, as a co-leader of the firm’s AI/ML Tactical Operations team, also frequently advises clients on the use of AI/ML during the life cycle of drugs and medical devices, including digital health products. \nAmanda advises clients during internal and government investigations.  She also assists in the negotiation and management of several consent decrees of injunction for pharmaceutical, medical device, food companies and compounding pharmacies.\nAmanda works closely with the firm's product liability team and is experienced in handling FDA issues in product liability litigation, including the development of supporting evidence, writing briefs, and preparing expert witnesses to testify.\nAmanda also has significant experience and expertise in FDA's regulation of tobacco products. Amanda J Klingler Partner University of Richmond University of Richmond School of Law Saint Louis University Saint Louis University School of Law Loyola University Chicago Loyola University Chicago School of Law District of Columbia Illinois Phillips Morris USA v. FDA, 202 F.Supp. 3d (D.D.C. 2016). Represented one of the plaintiffs in a successful legal challenge to an FDA guidance governing the Substantial Equivalence Review process for tobacco products. Member of a King \u0026amp; Spalding team serving as national coordinating counsel and trial counsel in product liability litigationinvolving GlaxoSmithKline’s antidepressant Paxil®, including in the Philadelphia Court of Common Pleas Mass Tort Program. Experience includes preparing fact and expert witnesses on FDA issues and briefing motions in limine and Daubertchallenges. Member of a King \u0026amp; Spalding team representing the manufacturer of FDA-cleared surgical gowns in nationwide litigation concerning the design, labeling, advertising and manufacture of the devices, including: a federal class action trial, the verdict from which is on appeal to the Ninth Circuit; a qui tam suit brought under the Federal False Claims Act in which the court granted defendants' motion to dismiss; and a federal Lanham Act lawsuit concerning allegations of false marketing. Experience includes working extensively with the Company's regulatory expert witness on the FDA-related issues in the litigation, leading the development of the Company's expert report and preparing the witness for his trial testimony. Assisted companies in preparing for FDA inspections, developing responses to FDA investigational observations (FDA-483 forms), and warning letters. Assisted pharmaceutical and medical device companies under investigation by FDA and the U.S. Department of Justice Office for alleged violations of the FDCA. Conducted internal investigations of pharmaceutical medical device manufacturers into potential quality systems and advertising and promotion violations to develop a risk profile and recommendation for reducing potential liability and risk exposure. Conducted FDA regulatory due diligence reviews of target medical device, pharmaceutical manufacturers, and compounding pharmacies. Counseled companies on radiation-emitting product requirements under the FDCA. Counseled companies on labeling and promotion requirements for FDA-regulated products. United States v. Franck’s Lab, 2011 WL 4031102 (M.D. Fla. Sept. 12, 2011). Lead associate for Franck’s Lab in successful defense of FDA enforcement action contending that traditional, state-licensed pharmacy compounding of veterinary medications violates FDA’s statute. Also served as the lead associate for Franck’s Lab in other FDA regulatory and state board of pharmacy matters. Hill Dermaceuticals, Inc. v. FDA, No. 1:11-cv-01950 (D.D.C.). Lead associate representing innovator drug manufacturer in litigation seeking to require FDA to withdraw its approval of purported generic formulations of manufacturer’s brand name products.","searchable_name":"Amanda J. Klingler","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null},{"id":432495,"version":1,"owner_type":"Person","owner_id":6494,"payload":{"bio":"\u003cp\u003ePeter\u0026nbsp;Kim is an associate in the Special Matters \u0026amp; Government Investigations practice\u0026nbsp;in King \u0026amp; Spalding's New York office. Peter helps clients navigate through\u0026nbsp;a broad range of complex disputes in response to significant cross-border risk, in addition to government regulatory matters, corporate internal investigations, and related civil litigation.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePeter specializes in representing companies in complex international\u0026nbsp;disputes involving\u0026nbsp;multiple jurisdictions around the world. He\u0026nbsp;provides clients with comprehensive\u0026nbsp;global litigation strategy, crisis management, and risk mitigation advice.\u003c/p\u003e\n\u003cp\u003eAdditionally, Peter\u0026nbsp;advises companies in connection with government regulatory and corporate internal investigations and has represented clients\u0026nbsp;in investigations and litigation brought by the DOJ, State AGs, and other agencies.\u003c/p\u003e\n\u003cp\u003ePeter received his J.D. from Columbia Law School, where he was\u0026nbsp;a Harlan Fiske Stone Scholar and a recipient of the Parker School Certificate for Achievement in International and Comparative Law. At Columbia, Peter served as\u0026nbsp;Executive Editor of the \u003cem\u003eColumbia Journal of Transnational Law\u003c/em\u003e.\u0026nbsp;He received his\u0026nbsp;M.A. from the Johns Hopkins School of Advanced International Studies and his B.A. from Columbia University. Prior to joining King \u0026amp; Spalding, Peter practiced in the New York office of Freshfields Bruckhaus Deringer.\u003c/p\u003e\n\u003cp\u003ePeter is admitted to practice in New York.\u003c/p\u003e","slug":"peter-kim","email":"pkim@kslaw.com","phone":null,"matters":["\u003cp\u003eAdvising and representing\u0026nbsp;\u003cstrong\u003emajor global technology companies\u003c/strong\u003e\u0026nbsp;with global litigation and risk mitigation strategy across multiple jurisdictions in matters relating to Russia and the international response to the Russia-Ukraine conflict.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on multiple internal investigations.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on key strategic regulatory risks.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on referrals to law enforcement in issues involving trade secret exfiltration.\u003c/p\u003e","\u003cp\u003eAdvising and representing\u0026nbsp;\u003cstrong\u003emultiple\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003emajor corporate clients\u003c/strong\u003e\u0026nbsp;in civil litigation and commercial and investment arbitration under the AAA, ICC, JAMS, and UNCITRAL rules in high-stakes breach-of-contract, post-M\u0026amp;A, construction, and investment treaty disputes.\u003c/p\u003e"],"taggings":{"tags":[],"meta_tags":[{"id":3249}]},"expertise":[{"id":11,"guid":"11.capabilities","index":0,"source":"capabilities"},{"id":14,"guid":"14.capabilities","index":1,"source":"capabilities"},{"id":118,"guid":"118.capabilities","index":2,"source":"capabilities"},{"id":81,"guid":"81.capabilities","index":3,"source":"capabilities"},{"id":128,"guid":"128.capabilities","index":4,"source":"capabilities"},{"id":111,"guid":"111.capabilities","index":5,"source":"capabilities"},{"id":107,"guid":"107.capabilities","index":6,"source":"capabilities"}],"is_active":true,"last_name":"Kim","nick_name":"Peter","clerkships":[],"first_name":"Peter","title_rank":9999,"updated_by":202,"law_schools":[{"id":485,"meta":{"degree":"J.D.","honors":"Harlan Fiske Stone Scholar","is_law_school":"1","graduation_date":null},"order":1,"pin_order":null,"pin_expiration":null}],"middle_name":"C. Y.","name_suffix":"","recognitions":null,"linked_in_url":"https://www.linkedin.com/in/petercykim/","seodescription":"Peter Kim is an associate in the Special Matters \u0026 Government Investigations practice in King \u0026 Spalding's New York office. Read more about him.","primary_title_id":2,"translated_fields":{"en":{"bio":"\u003cp\u003ePeter\u0026nbsp;Kim is an associate in the Special Matters \u0026amp; Government Investigations practice\u0026nbsp;in King \u0026amp; Spalding's New York office. Peter helps clients navigate through\u0026nbsp;a broad range of complex disputes in response to significant cross-border risk, in addition to government regulatory matters, corporate internal investigations, and related civil litigation.\u0026nbsp;[[--readmore--]]\u003c/p\u003e\n\u003cp\u003ePeter specializes in representing companies in complex international\u0026nbsp;disputes involving\u0026nbsp;multiple jurisdictions around the world. He\u0026nbsp;provides clients with comprehensive\u0026nbsp;global litigation strategy, crisis management, and risk mitigation advice.\u003c/p\u003e\n\u003cp\u003eAdditionally, Peter\u0026nbsp;advises companies in connection with government regulatory and corporate internal investigations and has represented clients\u0026nbsp;in investigations and litigation brought by the DOJ, State AGs, and other agencies.\u003c/p\u003e\n\u003cp\u003ePeter received his J.D. from Columbia Law School, where he was\u0026nbsp;a Harlan Fiske Stone Scholar and a recipient of the Parker School Certificate for Achievement in International and Comparative Law. At Columbia, Peter served as\u0026nbsp;Executive Editor of the \u003cem\u003eColumbia Journal of Transnational Law\u003c/em\u003e.\u0026nbsp;He received his\u0026nbsp;M.A. from the Johns Hopkins School of Advanced International Studies and his B.A. from Columbia University. Prior to joining King \u0026amp; Spalding, Peter practiced in the New York office of Freshfields Bruckhaus Deringer.\u003c/p\u003e\n\u003cp\u003ePeter is admitted to practice in New York.\u003c/p\u003e","matters":["\u003cp\u003eAdvising and representing\u0026nbsp;\u003cstrong\u003emajor global technology companies\u003c/strong\u003e\u0026nbsp;with global litigation and risk mitigation strategy across multiple jurisdictions in matters relating to Russia and the international response to the Russia-Ukraine conflict.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on multiple internal investigations.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on key strategic regulatory risks.\u003c/p\u003e","\u003cp\u003eAdvising a\u0026nbsp;\u003cstrong\u003emajor global technology company\u003c/strong\u003e\u0026nbsp;on referrals to law enforcement in issues involving trade secret exfiltration.\u003c/p\u003e","\u003cp\u003eAdvising and representing\u0026nbsp;\u003cstrong\u003emultiple\u003c/strong\u003e\u0026nbsp;\u003cstrong\u003emajor corporate clients\u003c/strong\u003e\u0026nbsp;in civil litigation and commercial and investment arbitration under the AAA, ICC, JAMS, and UNCITRAL rules in high-stakes breach-of-contract, post-M\u0026amp;A, construction, and investment treaty disputes.\u003c/p\u003e"]},"locales":["en"]},"secondary_title_id":null,"upload_assignments":{"headshot":[{"id":10553}]},"capability_group_id":2},"created_at":"2025-07-25T13:54:48.000Z","updated_at":"2025-07-25T13:54:48.000Z","searchable_text":"Kim{{ FIELD }}Advising and representing major global technology companies with global litigation and risk mitigation strategy across multiple jurisdictions in matters relating to Russia and the international response to the Russia-Ukraine conflict.{{ FIELD }}Advising a major global technology company on multiple internal investigations.{{ FIELD }}Advising a major global technology company on key strategic regulatory risks.{{ FIELD }}Advising a major global technology company on referrals to law enforcement in issues involving trade secret exfiltration.{{ FIELD }}Advising and representing multiple major corporate clients in civil litigation and commercial and investment arbitration under the AAA, ICC, JAMS, and UNCITRAL rules in high-stakes breach-of-contract, post-M\u0026amp;A, construction, and investment treaty disputes.{{ FIELD }}Peter Kim is an associate in the Special Matters \u0026amp; Government Investigations practice in King \u0026amp; Spalding's New York office. Peter helps clients navigate through a broad range of complex disputes in response to significant cross-border risk, in addition to government regulatory matters, corporate internal investigations, and related civil litigation. \nPeter specializes in representing companies in complex international disputes involving multiple jurisdictions around the world. He provides clients with comprehensive global litigation strategy, crisis management, and risk mitigation advice.\nAdditionally, Peter advises companies in connection with government regulatory and corporate internal investigations and has represented clients in investigations and litigation brought by the DOJ, State AGs, and other agencies.\nPeter received his J.D. from Columbia Law School, where he was a Harlan Fiske Stone Scholar and a recipient of the Parker School Certificate for Achievement in International and Comparative Law. At Columbia, Peter served as Executive Editor of the Columbia Journal of Transnational Law. He received his M.A. from the Johns Hopkins School of Advanced International Studies and his B.A. from Columbia University. Prior to joining King \u0026amp; Spalding, Peter practiced in the New York office of Freshfields Bruckhaus Deringer.\nPeter is admitted to practice in New York. Peter Kim lawyer Associate Columbia University Columbia University Columbia University Columbia University School of Law Johns Hopkins University  New York Advising and representing major global technology companies with global litigation and risk mitigation strategy across multiple jurisdictions in matters relating to Russia and the international response to the Russia-Ukraine conflict. Advising a major global technology company on multiple internal investigations. Advising a major global technology company on key strategic regulatory risks. Advising a major global technology company on referrals to law enforcement in issues involving trade secret exfiltration. Advising and representing multiple major corporate clients in civil litigation and commercial and investment arbitration under the AAA, ICC, JAMS, and UNCITRAL rules in high-stakes breach-of-contract, post-M\u0026amp;A, construction, and investment treaty disputes.","searchable_name":"Peter C. Y. Kim","is_active":true,"featured":null,"publish_date":null,"expiration_date":null,"blog_featured":null,"published_by":202,"capability_group_featured":null,"home_page_featured":null}]}}